Statistik Asas
| LEI | 54930079ULTBRXUQNR89 |
| CIK | 1043961 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Precipio, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| September 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 3, 2025 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employ |
|
| September 3, 2025 |
Exhibit 99.1 Precipio Terminates Its ATM Management Decision Further Reinforces Commitment to Responsible Capital Management NEW HAVEN, CT, (September 3rd, 2025) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), has terminated its ATM (At-The-Market) instrument with investment bank Alliance Global Partners (AGP). “Our Company is in a much stronger position today than it was whe |
|
| August 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 18, 2025 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer |
|
| August 18, 2025 |
Exhibit 99.1 Diagnostics Biotech Company NASDAQ: PRPO Founded in 2011 HQ: New Haven, CT DISCLAIM ER T HIS PRESENT AT ION HAS BEE N PREPARE D B Y P RE CIPIO IN C. (T HE “C O MPAN Y”) AND IS GENERA L BA CKGROUND IN FOR MAT I ON ABOUT T HE C O MPAN Y’S ACT IV IT IES AS O F T HE DAT E O F T HIS PRESENT AT ION . B Y AC CEPT ING T H IS PRESENT AT ION , T HE RE CIPIENT ACKNOW LEDGES AND AG REES T HAT A L |
|
| August 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00 |
|
| July 31, 2025 |
Exhibit 99.1 Precipio Announces Q2-2025 Shareholder Update Call Conference Call to be held on August 14th, 2025 at 5:00 PM EST NEW HAVEN, CT, (July 31st, 2025) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2025 corporate update call on August 14th, 2025 at 5:00 PM ET. The call will include updates on all of the company’s current core businesses. The c |
|
| July 31, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 31, 2025 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer I |
|
| June 17, 2025 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 17, 2025 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer I |
|
| June 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive |
|
| May 15, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 14, 2025 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer Id |
|
| May 15, 2025 |
Exhibit 99.1 Precipio Announces its Q1-2025 Financial Results Conference call to follow tomorrow, May 15 at 5 PM EST NEW HAVEN, CT, (May 14th, 2025) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The following are the highlights of the Company’s financial performance and outlook for 2025. “We remain confident in the Company’s trajectory, supporte |
|
| May 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0 |
|
| May 6, 2025 |
Exhibit 99.1 Precipio Announces Q1-2025 Shareholder Update Call Conference Call to be held on May 15th, 2025 at 5:00 PM EST NEW HAVEN, CT, (May 1st, 2025) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2025 corporate update call on May 15th, 2025 at 5:00 PM ET. The call will include updates on all of the company’s current core businesses. The conferenc |
|
| May 6, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 1, 2025 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer Ide |
|
| April 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitiv |
|
| April 30, 2025 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a- |
|
| April 10, 2025 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 9, 2025 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| April 10, 2025 |
Letter from Marcum LLP dated April 9, 2025 Exhibit 16.1 April 9, 2025 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Precipio, Inc. under Item 4.01 of its Form 8-K dated April 9, 2025. We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of Precipio, Inc. contained therein. Very tr |
|
| March 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36 |
|
| March 27, 2025 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name State of Incorporation or Organization Precipio Diagnostics, LLC Delaware Precipio SPV, Inc. Delaware CB4Cancer, LLC Delaware |
|
| March 27, 2025 |
Precipio, Inc. Insider Trading Policy Exhibit 19.1 PRECIPIO, INC. Insider Trading Policy Introduction The Board of Directors of Precipio, Inc. (“Precipio” or the “Company”) has adopted this Insider Trading Policy (the “Policy” or the “Insider Trading Policy”) to provide guidelines to all directors, officers, employees, associates and consultants of Precipio with respect to trading in the Company’s securities. This Policy has been desi |
|
| March 17, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 17, 2025 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State or other jurisdiction of incorporation) (Commission File Num |
|
| March 17, 2025 |
Exhibit 99.1 Precipio Announces Q4 and year-end 2024 Shareholder Update Call Conference Call to be held on March 31st, 2025 at 5:00 PM EST NEW HAVEN, CT, (March 17th, 2025) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4 and year end 2024 corporate update call on March 31st, 2025 at 5:00 PM ET. The call will include updates on all of the company’s curre |
|
| January 21, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 14, 2025 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employe |
|
| January 16, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 16, 2025 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employe |
|
| January 16, 2025 |
As filed with the Securities and Exchange Commission on January 16, 2025 S-8 1 tm253587d1s-8.htm FORM S-8 As filed with the Securities and Exchange Commission on January 16, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Precipio, Inc. (Exact name of registrant as specified in its charter) Delaware 91-1789357 (State or other jurisdiction of incorporation |
|
| January 16, 2025 |
Exhibit 99.1 Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs These options vest when PRPO stock price is 5x the exercise price NEW HAVEN, CT, (January 16, 2025) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that options granted to senior management on January 14 would vest when the 10-day VWAP of the Company’s co |
|
| January 16, 2025 |
EX-FILING FEES 4 tm253587d1ex107.htm EXHIBIT 107 Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Precipio, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registra |
|
| November 7, 2024 |
Financial Statements and Exhibits, Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 6, 2024 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employe |
|
| November 7, 2024 |
Exhibit 99.1 Precipio Announces Q3-2024 Shareholder Update Call Conference Call to be held on November 18, 2024, at 5:00 PM EST NEW HAVEN, CT, (November 6, 2024) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2024 corporate update call on November 18th at 5:00 PM ET. The call will provide commentary on Precipio's Q3-2024 10-Q filed today, including fin |
|
| November 6, 2024 |
Form of Notice of Stock Option Repricing Exhibit 10.1 Notice of Option Repricing Precipio, Inc. Re:Notice of Stock Option Repricing Dear Precipio Optionholder: We are pleased to inform you that the Board of Directors of Precipio, Inc. (the “Corporation”) has approved a reduction in the per share exercise price of certain of your outstanding stock option(s) to purchase shares of the Corporation’s common stock (the “Option Repricing”). As |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| September 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 30, 2024 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| August 15, 2024 |
Exhibit 99.1 Precipio Announces Q2-2024 Shareholder Update Call Conference Call to be held on August 19, 2024 at 5:00 PM EST NEW HAVEN, CT, (August 15, 2024) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2024 corporate update call on August 19th at 5:00 PM ET. The call will include updates on the company’s current core businesses. The conference call |
|
| August 15, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 15, 2024 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer |
|
| August 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00 |
|
| August 2, 2024 |
PRPO / Precipio, Inc. / EKLUND DAVID A - SCHEDULE 13G Passive Investment SC 13G 1 e77479529.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* PRECIPIO, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 74019L107 (CUSIP Number) July 25, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate |
|
| June 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 21, 2024 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer I |
|
| June 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitiv |
|
| June 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitiv |
|
| May 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0 |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 1, 2024 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State or other jurisdiction of incorporation) (Commission File Number |
|
| May 6, 2024 |
Exhibit 99.1 Precipio Secures a short-term $500K Credit Facility Loan will supplement any temporary cashflow deficit related to cash collections delay due to Change Healthcare cybersecurity attack NEW HAVEN, CT, (May 6th, 2024) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces it has secured a short-term loan facility of $500K to deal with any delays in cash collectio |
|
| May 6, 2024 |
Exhibit 10.1 Business Loan and Security Agreement April 19, 2024 This Business Loan and Security Agreement is an important legal document. Borrower should keep this document for Borrower’s records. Borrower: PRECIPIO INC. AND PRECIPIO DIAGNOSTICS LLC AND PRECIPIO SPV, INC. 4 Science Park New Haven, CT 06511 EIN:91-1789357 Lender: Altbanq Lending LLC Disbursement Amount: Amount of Loan less fees an |
|
| May 1, 2024 |
Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 1, 2024 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State or other jurisdiction of incorporation) (Commission File Number |
|
| April 29, 2024 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a- |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitiv |
|
| April 8, 2024 |
Up to $1,061,478 of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-271277 PROSPECTUS SUPPLEMENT (To prospectus dated on April 25, 2023) Up to $1,061,478 of Common Stock This prospectus supplement amends and supplements the information in the prospectus supplement, dated April 25, 2023 (the “Prior Prospectus Supplement”), filed with the Securities and Exchange Commission as a part of our registration statement |
|
| March 29, 2024 |
As filed with the Securities and Exchange Commission on March 29, 2024 As filed with the Securities and Exchange Commission on March 29, 2024 Registration No. |
|
| March 29, 2024 |
Exhibit 97.1 PRECIPIO INC COMPENSATION RECOVERY POLICY Adopted as of June 21, 2023 Precipio Inc, a Delaware corporation (the “Company”), has adopted a Compensation Recovery Policy (this “Policy”) as described below. 1.Overview The Policy sets forth the circumstances and procedures under which the Company shall recover Erroneously Awarded Compensation from current and former Executive Officers of t |
|
| March 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36 |
|
| March 29, 2024 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name State of Incorporation or Organization Precipio Diagnostics, LLC Delaware Precipio SPV, Inc. Delaware CB4Cancer, LLC Delaware |
|
| March 29, 2024 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Precipio, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Precipio, Inc. Amended and Restat |
|
| March 26, 2024 |
Exhibit 99.1 Precipio Announces Year end 2023 Shareholder Update Call Conference Call to be held on April 1st, 2024 at 5:00 PM EST NEW HAVEN, CT, (March 25th, 2024) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its year end 2023 corporate update call on April 1st, 2024 at 5:00 PM ET. The call will include updates on all of the company’s current core business |
|
| March 26, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 26, 2024 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State or other jurisdiction of incorporation) (Commission File Num |
|
| January 19, 2024 |
Up to $865,889 of Common Stock Filed Pursuant to Rule 424(b)(5) Registration No. 333-271277 PROSPECTUS SUPPLEMENT (To prospectus dated on April 25, 2023) Up to $865,889 of Common Stock This prospectus supplement amends and supplements the information in the prospectus supplement, dated April 25, 2023 (the “Prior Prospectus Supplement”), filed with the Securities and Exchange Commission as a part of our registration statement on |
|
| January 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 1, 2024 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| January 2, 2024 |
Exhibit 99.1 Precipio Announces Christina Valauri joins the Board of Directors Douglas Fisher, MD will step down as Director, and remain as a board observer NEW HAVEN, CT, Globenewswire – (January 2, 2024) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is pleased to welcome Christina Valauri to its board of directors effective Jan 1st, 2024. Ms. Valauri is joining Precipio’s |
|
| December 14, 2023 |
Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 EX-99.1 2 tm2332910d1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 NEW HAVEN, CT, Globenewswire – (December 14, 2023) – Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) shares thoughts and reflections looking back at 2023, and forward to 2024. At the start of 2023, management set three goals, all focused on |
|
| December 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 14, 2023 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employ |
|
| November 16, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 16, 2023 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employ |
|
| November 16, 2023 |
Exhibit 99.1 Precipio Announces Q3-2023 Shareholder Update Call Conference Call to be held on November 20th, 2023 at 5:00 PM EST NEW HAVEN, CT, (November 16th, 2023) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2023 corporate update call on November 20th, 2023 at 5:00 PM ET. The call will include updates on all of the company’s current core businesse |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| October 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 6, 2023 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer |
|
| September 21, 2023 |
Exhibit 99.1 Precipio Takes Final Step Towards Regaining Nasdaq Compliance Company announces 1-for-20 reverse stock split NEW HAVEN, CT - (September 21, 2023) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) today announced that it has implemented a 1-for-20 reverse stock split of outstanding shares of the company's common stock in order to regain compliance with the Nasdaq min |
|
| September 21, 2023 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PRECIPIO, INC. (Pursuant to Section 242 of the General Corporation Law of the State of Delaware) THE UNDERSIGNED, being a duly appointed and authorized officer of Precipio, Inc., a corporation organized and existing under and by virtue of the laws of the State of Delaware (the “Corporation”), does he |
|
| September 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 21, 2023 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Emplo |
|
| August 14, 2023 |
Exhibit 99.1 Precipio Announces Q2-2023 Shareholder Update Call Conference Call to be held on August 17, 2023 at 5:00 PM EST NEW HAVEN, CT, (August 10th, 2023) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2023 corporate update call on August 17th at 5:00 PM ET. The call will include updates on all of the company’s current core businesses. The confere |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 10, 2023 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00 |
|
| July 17, 2023 |
Precipio, Inc. 4 Science Park New Haven, Connecticut 06511 Precipio, Inc. 4 Science Park New Haven, Connecticut 06511 July 17, 2023 Via EDGAR Transmission Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Precipio, Inc.: Registration Statement on Form S-1 filed July 7, 2023 (File No. 333-273172) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”) |
|
| July 7, 2023 |
As filed with the U.S. Securities and Exchange Commission on July 7, 2023 As filed with the U.S. Securities and Exchange Commission on July 7, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Precipio, Inc. (Exact name of registrant as specified in its charter) Delaware 3826 91-1789357 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Emp |
|
| July 7, 2023 |
Calculation of Filing Fee Tables. Exhibit 107 Calculation of Filing Fee Tables S-1 (Form Type) Precipio, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity Common S |
|
| July 7, 2023 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name State of Incorporation or Organization Precipio Diagnostics, LLC Delaware Precipio SPV, Inc. Delaware |
|
| June 15, 2023 |
Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 15, 2023 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer I |
|
| June 12, 2023 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of June 8, 2023, between Precipio, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”). WHEREAS, subject to the terms and conditions set forth |
|
| June 12, 2023 |
Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| June 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2023 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (IRS Employer Ident |
|
| June 12, 2023 |
Exhibit 10.2 LOCK-UP AGREEMENT June [], 2023 A.G.P./Alliance Global Partners 590 Madison Avenue New York, New York 10022 Re: Precipio, Inc.—Proposed Offering of Securities Ladies and Gentlemen: The undersigned, a holder of common stock, par value $0.01 per share (“Shares”), or rights to acquire Shares, of Precipio, Inc., a company incorporated under the laws of the State of Delaware (the “Company” |
|
| June 12, 2023 |
Exhibit 99.1 Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement NEW HAVEN, CT, (June 8th, 2023) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 4,125,000 shares of the Company’s common stoc |
|
| June 12, 2023 |
Exhibit 4.1 Pre-Funded WARRANT To purchase Shares of Common Stock PRECIPIO, INC. Warrant Shares: Initial Exercise Date: June 12, 2023 THIS Pre-Funded WARRANT to Purchase Shares of Common Stock (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time |
|
| June 12, 2023 |
Exhibit 1.1 June 9, 2023 CONFIDENTIAL Precipio, Inc. Attention: Ilan Danieli 4 Science Park 3rd Floor New Haven, CT 06511 Dear Mr. Ilan Danieli, The purpose of this letter (this “Agreement”) is to confirm the engagement of A.G.P./Alliance Global Partners (“A.G.P.”) by Precipio, Inc. (the “Company”) to render Financial Services (as defined below) to the Company. 1. Services. During the term of this |
|
| June 9, 2023 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-271277 Prospectus supplement (To prospectus dated April 25, 2023) 4,125,000 shares of common stock Pre-funded warrants to purchase up to 319,445 shares of common stock We are offering 4,125,000 shares of our common stock, par value $0.01 per share at a price of $0.45 per share and pre-funded warrants (the “Pre-funded Warrants”) to purchase 3 |
|
| May 16, 2023 |
Exhibit 99.1 Precipio Announces Q1-2023 Shareholder Update Call Conference Call to be held on May 17, 2023 at 5:00 PM EST NEW HAVEN, CT, (May 15th, 2023) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2023 corporate update call on May 17th at 5:00 PM ET. The call will include updates on all of the company’s current core businesses. The conference call |
|
| May 16, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 15, 2023 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer Id |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0 |
|
| April 27, 2023 |
Exhibit 99.1 Precipio Granted 180-day Extension From NASDAQ To Regain Compliance Extension will enable the Company to execute on its growth and advance toward breakeven NEW HAVEN, CT, Globenewswire – (April 27, 2023) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces notification by the NASDAQ Stock Market that the Company has been granted a 180-day extension to allow |
|
| April 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 27, 2023 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer |
|
| April 25, 2023 |
Precipio, Inc. 4 Science Park New Haven, Connecticut 06511 CORRESP 1 filename1.htm Precipio, Inc. 4 Science Park New Haven, Connecticut 06511 April 25, 2023 Via EDGAR Transmission Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Precipio Inc.: Registration Statement on Form S-3/A filed April 25, 2023 (File No. 333-271277) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of |
|
| April 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definit |
|
| April 25, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a- |
|
| April 25, 2023 |
EX-1.1 2 tm2313545d1ex1-1.htm EXHIBIT 1.1 Exhibit 1.1 PRECIPIO, INC. COMMON STOCK SALES AGREEMENT April 14, 2023 A.G.P./Alliance Global Partners 590 Madison Avenue New York, NY 10022 Ladies and Gentlemen: Precipio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (the “Sales Agent”), as follows: 1. Issuance and Sale of Sha |
|
| April 25, 2023 |
Form of indenture for senior debt securities and the related form of senior debt Exhibit 4.3 PRECIPIO, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Senior Debt Securities TABLE OF CONTENTS1 ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.01 Designation and Terms of Securities 4 Section 2.02 Form of Securities and Trustee’s Certificate 6 Secti |
|
| April 25, 2023 |
Exhibit 4.4 PRECIPIO, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Subordinated Debt Securities TABLE OF CONTENTS1 ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.01 Designation and Terms of Securities 4 Section 2.02 Form of Securities and Trustee’s Certificate 6 |
|
| April 25, 2023 |
As filed with the Securities and Exchange Commission on April 25, 2023 As filed with the Securities and Exchange Commission on April 25, 2023 Registration No. |
|
| April 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 14, 2023 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer |
|
| April 17, 2023 |
Exhibit 1.1 PRECIPIO, INC. COMMON STOCK SALES AGREEMENT April 14, 2023 A.G.P./Alliance Global Partners 590 Madison Avenue New York, NY 10022 Ladies and Gentlemen: Precipio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (the “Sales Agent”), as follows: 1. Issuance and Sale of Shares. The Company agrees that, from time to |
|
| April 14, 2023 |
Exhibit 1.1 PRECIPIO, INC. COMMON STOCK SALES AGREEMENT April 14, 2023 A.G.P./Alliance Global Partners 590 Madison Avenue New York, NY 10022 Ladies and Gentlemen: Precipio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with A.G.P./Alliance Global Partners (the “Sales Agent”), as follows: 1. Issuance and Sale of Shares. The Company agrees that, from time to |
|
| April 14, 2023 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Precipio, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit (2) Maximum Aggregate Offering Price(1)(3) Fee Rate Amount of Registratio |
|
| April 14, 2023 |
Form of indenture for senior debt securities and the related form of senior debt Exhibit 4.3 PRECIPIO, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Senior Debt Securities TABLE OF CONTENTS1 ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.01 Designation and Terms of Securities 4 Section 2.02 Form of Securities and Trustee’s Certificate 6 Secti |
|
| April 14, 2023 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6 |
|
| April 14, 2023 |
Exhibit 4.4 PRECIPIO, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Subordinated Debt Securities TABLE OF CONTENTS1 ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.01 Designation and Terms of Securities 4 Section 2.02 Form of Securities and Trustee’s Certificate 6 |
|
| April 14, 2023 |
As filed with the Securities and Exchange Commission on April 14, 2023 Registration No. |
|
| March 30, 2023 |
Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Precipio, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Precipio, Inc. Amended and Restate |
|
| March 30, 2023 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name State of Incorporation or Organization Precipio Diagnostics, LLC Delaware Precipio SPV, Inc. Delaware |
|
| March 30, 2023 |
Exhibit 10.15 EXECUTION COPY FACTORING AGREEMENT BETWEEN CULAIN CAPITAL FUNDING LLC (“BUYER”) AND PRECIPIO, INC. (“SELLER”) DATED MARCH 27, 2023 TABLE OF CONTENTS 1. DEFINITIONS 1 2. ASSIGNMENT OF RECEIVABLES; OFFER FOR SALE OF ELIGIBLE RECEIVABLES BY SELLER; PURCHASE OF ELIGIBLE RECEIVABLES BY BUYER 1 2.1. Offer of Receivables for Purchase 1 2.2. Funding Requests; Deliveries 1 2.3. Sales of Recei |
|
| March 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36 |
|
| March 30, 2023 |
As filed with the Securities and Exchange Commission on March 30, 2023 As filed with the Securities and Exchange Commission on March 30, 2023 Registration No. |
|
| March 29, 2023 |
Exhibit 99.1 Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call Conference Call to be held on Monday, April 3rd, 2023 at 5:00 PM EST NEW HAVEN, CT, Globenewswire – (March 28th, 2023) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4-2022 and year end shareholder update call on Monday, April 3rd at 5:00 PM ET. The call will include |
|
| March 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 29, 2023 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer |
|
| November 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 18, 2022 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employ |
|
| November 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 4, 2022 |
Exhibit 99.1 Precipio Announces Third Quarter Shareholder Update Call Conference Call to be held on Monday, November 14th, 2022 at 5:00 PM ET NEW HAVEN, CT, Globenewswire – (November 2nd, 2022) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2022 shareholder update call on Monday, November 14th at 5:00 PM ET. The call will include updates on the Company |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 2, 2022 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employe |
|
| October 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 28, 2022 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employe |
|
| September 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 16, 2022 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State or other jurisdiction of incorporation) (Commission File |
|
| September 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 15, 2022 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State or other jurisdiction of incorporation) (Commission File |
|
| August 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 8, 2022 |
Exhibit 99.1 Precipio Announces Second Quarter Shareholder Update Call Conference Call to be held on Monday, August 15th, 2022 at 5:00 PM EST NEW HAVEN, CT, Globenewswire ? (August 8th, 2022) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2022 shareholder update call on Monday, August 15th at 5:00 PM ET. The call will include updates on the Company?s c |
|
| August 8, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 8, 2022 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer |
|
| July 21, 2022 |
Exhibit 99.1 Precipio to distribute HemeScreen? through Fisher Healthcare channel Agreement Enhances Precipio?s Product Reach to US Laboratories NEW HAVEN, CT ? (Globe Newswire) ? (July 20th, 2022) ? Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has entered into an agreement with Fisher Healthcare, a part of Thermo Fisher Scientific to distribute its p |
|
| July 21, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 20, 2022 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer I |
|
| July 6, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 5, 2022 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State of incorporation) (Commission File Number) (IRS Employer Ident |
|
| June 15, 2022 |
Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote Exhibit 99.1 Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote Meeting Adjourned, new meeting set for July 5th at 10am EDT NEW HAVEN, Conn., June 14, 2022 (GLOBE NEWSWIRE) - Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that the Company?s 2022 Annual Meeting of Stockholders was adjourned due to the fact that the percentage of |
|
| June 15, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 13, 2022 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware 001-36439 91-1789357 (State of incorporation) (Commission File Number) (IRS Employer Iden |
|
| June 13, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 13, 2022 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer I |
|
| June 13, 2022 |
Exhibit 99.1 Page (NASDAQ: PRPO) A Cancer Diagnostics Solutions Company 2022 Corporate Presentation DISCLAIMER This presentation has been prepared by Precipio Inc.(the ?Company?) and is general background information about the Company?s activities as of the date of this presentation. By accepting this presentation, the recipient acknowledges and agrees that all of the information contained herein |
|
| May 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| April 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive |
|
| April 28, 2022 |
DEF 14A 1 ny20003388x1def14a.htm DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the C |
|
| March 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 30, 2022 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT ? ? Name State of Incorporation or Organization Precipio Diagnostics, LLC Delaware Precipio SPV, Inc. Delaware ? ? |
|
| March 23, 2022 |
Exhibit 99.1 Precipio Announces 2021 Fourth Quarter and Year-End Shareholder Update Call Conference Call to be held on Monday, April 4th, 2022 at 5:00 PM EST NEW HAVEN, CT, Globenewswire ? (March 22nd, 2022) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4-2021 and year end shareholder update call on Monday, April 4th at 5:00 PM ET. The call will include |
|
| March 23, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 22, 2022 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer |
|
| March 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 21, 2022 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer |
|
| March 21, 2022 |
Exhibit 10.1 ? New Hire x? Change ? Separation EFFECTIVE DATE 3/21/2022 LAST NAME FIRST MIDDLE Gage Matthew SOCIAL SECURITY NUMBER DEPARTMENT ?Finance SHIFT CLOCK/PAYROLL NO. COMPLETE THIS SECTION FOR NEW HIRES ONLY ? Rehire ? Addition to Staff ? Replacement For ADDRESS CITY STATE ZIP PHONE NO. BIRTH DATE SEX ? M ? F MARITAL STATUS ? S ? M ? W ? D NUMBER OF DEPENDENTS CLASSIFICATION ? Non-Exempt ? |
|
| March 21, 2022 |
Exhibit 99.1 Precipio Inc. Announces the Resignation of its Chief Financial Officer and Appointment of Interim CFO NEW HAVEN CT ? (March 21, 2022) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that Mr. Carl Iberger, Precipio?s CFO for the past five years, is resigning as the Chief Financial Officer effective as of today, March 21st, 2022. Mr. Iberger wishes |
|
| February 28, 2022 |
Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022 Exhibit 99.1 Precipio Releases Year-End 2021 Preliminary Unaudited Results and Outlook for 2022 NEW HAVEN CT, (February 24, 2022) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced its unaudited and preliminary results for 2021. The Company anticipates posting revenues of $8.9 million, an increase of $2.8 million from 2020, representing a 45% year-over-year incre |
|
| February 28, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 24, 2022 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employ |
|
| November 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 2, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 1, 2021 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employe |
|
| November 2, 2021 |
Exhibit 99.1 Precipio Announces Q3-2021 Shareholder Update Call Conference Call to be held on Monday, November 15th, 2021 at 5:00 PM EST NEW HAVEN, CT, (November 1st, 2021) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2021 update call on Monday, November 15th at 5:00 PM ET. The call will include updates on the company?s current core businesses. The c |
|
| August 23, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 20, 2021 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 001-36439 91-1789357 (State of Incorporation) (Commission File Number) (I.R.S. Employer |
|
| August 23, 2021 |
Exhibit 99.1 Precipio Reschedules Q2-2021 Shareholder Update Call Due to a schedule conflict, the call is moved to Thursday August 26th at 5:00PM EST NEW HAVEN, CT, (August 20th, 2021) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be rescheduling its Q2-2021 update call from Monday August 23rd to Thursday August 26th at 5:00 PM ET due to a schedule conflict. The confer |
|
| August 13, 2021 |
Exhibit 99.1 Precipio Announces Q2-2021 Shareholder Update Call Conference Call to be held on Monday, August 23rd, 2021 at 5:00 PM EST NEW HAVEN, CT, (August 12th, 2021) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2021 update call on Monday, August 23rd at 5:00 PM ET. The call will include updates on all of the company?s current core businesses. The |
|
| August 13, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 12, 2021 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) ? Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employ |
|
| August 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| August 3, 2021 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0101 Washington, D. |
|
| July 28, 2021 |
Exhibit 99.1 Precipio Announces Preliminary Unaudited Q2-2021 Revenues of $2.3M Increase of 65% YoY, and 29% from Q1-2021 due to strong Pathology Growth and HemeScreen NEW HAVEN, CT, (July 28, 2021) ? Specialty diagnostics Company Precipio, Inc. (NASDAQ: PRPO), announces preliminary unaudited revenues for Q2-2021 demonstrating continued substantial YoY and quarterly growth. The two key factors dri |
|
| July 28, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 28, 2021 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer I |
|
| June 21, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 18, 2021 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 001-36439 (Commission File Number) 91-1789357 (IRS Employer Iden |
|
| June 17, 2021 |
144 1 tm2119981-1144seq1.htm FORM 144 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number 3235-0101 Expires: July 31, 2023 Estimated average burden hours per response 1.00 FORM 144 SEC USE ONLY NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 DOCUMENT SEQUENCE NO. ATTENTION: Transmit for filing 3 copies of this |
|
| June 15, 2021 |
Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 15, 2021 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-36439 (Commission File Number) 91-1789 |
|
| June 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 15, 2021 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-36439 (Commission File Number) 91-1789 |
|
| May 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. 1) Filed by the Registrant x Filed by a Party other than the Registrant?? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e |
|
| May 17, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 14, 2021 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer Id |
|
| May 17, 2021 |
Exhibit 99.1 Precipio Announces Q1-2021 and year-end Shareholder Update Call Conference Call to be held on Thursday, May 20th, 2021 at 5:00 PM EST NEW HAVEN, CT, (May 14th, 2021) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q1-2021 corporate update call on Thursday, May 20th at 5:00 PM ET. The call will include updates on all of the company?s current co |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| April 29, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive |
|
| April 29, 2021 |
DEF 14A 1 nc10023643x1def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as |
|
| April 2, 2021 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 2, 2021 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer I |
|
| April 2, 2021 |
Up to $22,000,000 Common Stock Filed pursuant to Rule 424(b)(5) Registration No. 333-237445 The information in this prospectus supplement is not complete and may be changed. A registration statement relating to these securities became effective under the Securities Act of 1933, as amended. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities, and we are not soliciting |
|
| April 2, 2021 |
Exhibit 1.01 PRECIPIO, INC. COMMON STOCK SALES AGREEMENT April 2, 2021 A.G.P./Alliance Global Partners 590 Madison Avenue, 28th Floor New York, NY 10022 Ladies and Gentlemen: Precipio, Inc., a Delaware corporation (the ?Company?), confirms its agreement (this ?Agreement?) with A.G.P./Alliance Global Partners, as follows: 1. Issuance and Sale of Shares. The Company agrees that, from time to time du |
|
| March 29, 2021 |
Table of Contents ? ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| March 29, 2021 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT ? ? Name State of Incorporation or Organization Precipio Diagnostics, Inc. Delaware Precipio SPV, Inc. Delaware ? ? |
|
| March 18, 2021 |
Financial Statements and Exhibits, Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 18, 2021 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer |
|
| March 18, 2021 |
Exhibit 99.1 Precipio Announces Q4-2020 and year-end Shareholder Update Call Conference Call to be held on Wednesday, March 31st, 2021 at 5:00 PM EST NEW HAVEN, CT, (March 18th, 2021) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4-2020 and year end corporate update call on Wednesday, March 31st at 5:00 PM ET. The call will include updates on all of the |
|
| March 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 1, 2021 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-36439 (Commission File Number) 91-1789 |
|
| March 3, 2021 |
Exhibit 99.2 Mr. Ron Andrews joins Precipio?s Board of Directors Company Strengthens Depth of Expertise in Products Industry NEW HAVEN, CT, (March 3, 2021) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces that Mr. Ron Andrews has joined the company?s Board of Directors. As the company continues to build its products division around commercializing the technologies it |
|
| March 3, 2021 |
Mr. Richard Sandberg is appointed Chairman of Precipio’s Board of Directors Exhibit 99.1 Mr. Richard Sandberg is appointed Chairman of Precipio’s Board of Directors NEW HAVEN, CT, (March 3, 2021) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the appointment of Mr. Richard Sandberg as Chairman of the Board of Directors. Dr. Douglas Fisher will step down as Chairman and maintain his role as a Director on the company’s board. Mr. Sandberg has |
|
| November 13, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q Table of Contents ? UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 12, 2020 |
Exhibit 99.1 Precipio Announces Q3-2020 Shareholder Update Call Conference Call to be held on Thursday, November 19th, 2020 at 5:00 PM EST NEW HAVEN, CT, (November 11th, 2020) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2020 corporate update call on Thursday, November 19th at 5:00 PM ET. The call will include updates on the company’s current core bu |
|
| November 12, 2020 |
Financial Statements and Exhibits, Regulation FD Disclosure - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 11, 2020 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employ |
|
| September 4, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 4, 2020 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employ |
|
| September 4, 2020 |
Exhibit 99.1 Precipio Announces a Shareholder Call to Discuss its COVID-19 Progress and Future Plans Ilan Danieli, Precipio CEO, will address questions from shareholders related to company COVID-19 strategy NEW HAVEN, CT, (September 4th, 2020) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting a shareholder call to address questions related to the company's COVID |
|
| August 28, 2020 |
8-K 1 tm2029831d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 26, 2020 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-364 |
|
| August 13, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00 |
|
| August 7, 2020 |
Exhibit 99.1 Precipio Announces Q2-2020 Corporate Update Call For Shareholders Conference Call to be held on Monday, August 17th, 2020 at 5:00 PM EST NEW HAVEN, CT, (August 7th, 2020) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2020 corporate update call on Monday, August 17th at 5:00 PM ET. The call will include updates on the company’s current cor |
|
| August 7, 2020 |
Financial Statements and Exhibits, Regulation FD Disclosure UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 7, 2020 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer |
|
| July 22, 2020 |
Exhibit 99.1 Precipio Announces Q2-2020 Unaudited Pathology Services Revenue Increased Approximately 50% over Q1’20 NEW HAVEN, CT, (July 22, 2020) – Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced its preliminary unaudited revenues for its pathology services increased from $0.8M in Q1’20, to an estimated (unaudited) $1.3M in Q2’20, an increase of approximately 50% quarter-ov |
|
| July 22, 2020 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 22, 2020 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer I |
|
| July 13, 2020 |
8-K 1 tm2024699d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 9, 2020 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-36439 |
|
| July 7, 2020 |
As filed with the Securities and Exchange Commission on July 6, 2020 Registration No. |
|
| July 7, 2020 |
Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933, as amended Registration 333-239506 PROSPECTUS Up to 4,500,000 Common Stock This prospectus relates to the offer and sale of up to 4,500,000 shares of common stock, par value $0. |
|
| July 7, 2020 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name State of Incorporation or Organization Precipio Diagnostics, Inc. Delaware Precipio SPV, Inc. Delaware |
|
| July 7, 2020 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name State of Incorporation or Organization Precipio Diagnostics, Inc. Delaware Precipio SPV, Inc. Delaware |
|
| July 7, 2020 |
As filed with the Securities and Exchange Commission on July 7, 2020 Registration No. |
|
| July 2, 2020 |
PRECIPIO, INC. 4 Science Park New Haven, Connecticut 06511 July 2, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Precipio, Inc. Registration Statement on Form S-1 File No. 333-239506 Ladies and Gentleman, In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests th |
|
| June 30, 2020 |
8-K 1 tm2023833d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 29, 2020 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-36439 |
|
| June 26, 2020 |
Registration Statement - FORM S-1 As filed with the Securities and Exchange Commission on June 26, 2020 Registration No. |
|
| June 26, 2020 |
Submission of Matters to a Vote of Security Holders 8-K 1 tm2023568d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 25, 2020 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 001-36439 (Commission File Numb |
|
| June 26, 2020 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name State of Incorporation or Organization Precipio Diagnostics, Inc. Delaware Precipio SPV, Inc. Delaware |
|
| June 3, 2020 |
8-K 1 tm2021757d18k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 3, 2020 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-36439 |
|
| May 14, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 0 |
|
| May 13, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 12, 2020 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer Id |
|
| May 13, 2020 |
Exhibit 99.1 Precipio Announces Q1-2020 Corporate Update Call For Shareholders Conference Call to be held on Tuesday, May 19th, 2020 at 5:00 PM EST NEW HAVEN, CT, (May 12th, 2020) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Quarter1-2020 corporate update call on Tuesday, May 19th at 5:00 PM ET. The conference call may be accessed by calling 844-695-551 |
|
| May 1, 2020 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 29, 2020 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-36439 (Commission File Number) 91-178 |
|
| April 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definit |
|
| April 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ⌧ Filed by a Party other than the Registrant ◻ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive |
|
| April 24, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 24, 2020 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer |
|
| April 24, 2020 |
Exhibit 10.1 SBAU.S Small Business AdministrationU.S. Small Business AdministrationNOTESBA Loan #SBA Loan Name:Date:Loan Amount:Interest Rate:Operating Company: Lender: Webster Bank, National Association1.PROMISETOPAY:InReturnfortheLoan,BorrowerpromisestopaytotheorderofLendertheamountofDollars,interestontheunpaidPrincipalBalance,andallotheramountsrequiredbythisNote.2.DEFINITIONS:(totheextentapplic |
|
| April 13, 2020 |
Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933, as amended Registration 333-237441 PROSPECTUS Up to 1,770,000 Common Stock This prospectus relates to the offer and sale of up to 1,700,000 shares of common stock, par value $0. |
|
| April 9, 2020 |
Precipio, Inc. 4 Science Park New Haven, CT 06511 April 9, 2020 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Precipio, Inc. Registration Statement on Form S-3/A File No. 333-237445 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Precipio, Inc. (the “ |
|
| April 9, 2020 |
Precipio, Inc. 4 Science Park New Haven, CT 06511 April 9, 2020 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Precipio, Inc. Registration Statement on Form S-1/A File No. 333-237441 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Precipio, Inc. (the “ |
|
| April 9, 2020 |
PRPO / Precipio Inc S-3/A - - S-3/A As filed with the Securities and Exchange Commission on April 9, 2020 Registration No. |
|
| April 9, 2020 |
Exhibit 4.2 FORM OF SUBORDINATED INDENTURE by and between PRECIPIO, INC. as Issuer, and , as Trustee Dated as of TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1.01 Definitions 1 SECTION 1.02 Incorporation by Reference of Trust Indenture Act 5 SECTION 1.03 Rules of Construction 5 ARTICLE II THE SECURITIES SECTION 2.01 Unlimited in Amount, Issuable in Series 6 S |
|
| April 8, 2020 |
PRPO / Precipio Inc S-1/A - - S-1/A As filed with the Securities and Exchange Commission on April 8, 2020 Registration No. |
|
| April 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 7, 2020 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer I |
|
| April 7, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001- |
|
| March 27, 2020 |
Exhibit 10.2 Execution Version REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made and entered into as of March 26, 2020, by and between PRECIPIO, INC., a Delaware corporation (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise |
|
| March 27, 2020 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name State of Incorporation or Organization Precipio Diagnostics, Inc. Delaware Precipio SPV, Inc. Delaware |
|
| March 27, 2020 |
PRPO / Precipio Inc S-3 - - S-3 As filed with the Securities and Exchange Commission on March 27, 2020 Registration No. |
|
| March 27, 2020 |
PRPO / Precipio Inc S-1 - Registration Statement - FORM S-1 As filed with the Securities and Exchange Commission on March 27, 2020 Registration No. |
|
| March 27, 2020 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name State of Incorporation or Organization Precipio Diagnostics, Inc. Delaware Precipio SPV, Inc. Delaware |
|
| March 27, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 27, 2020 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State of incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer |
|
| March 27, 2020 |
Exhibit 4.7 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of our securities is intended as a summary only and is qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation and Bylaws as amended, which are filed as exhibits to the annual report on Form 10‑K of which t |
|
| March 27, 2020 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001‑36 |
|
| March 27, 2020 |
Exhibit 10.52 AMENDMENT NO. 1 TO 8% SENIOR SECURED CONVERTIBLE PROMISSORY NOTES This Amendment No. 1 to 8% Senior Secured Convertible Promissory Notes (this “Amendment”), dated as of March, 2020 (the “Effective Date”), is entered into by and between Precipio, Inc., a Delaware corporation, (the “Company”), having its principal place of business at 4 Science Park, New Haven, CT 06511, (the “Company” |
|
| March 27, 2020 |
Exhibit 10.1 Execution Version PURCHASE AGREEMENT PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of March 26, 2020, by and between PRECIPIO, INC., a Delaware corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (the “Investor”). WHEREAS: Subject to the terms and conditions set forth in this Agreement, the Company wishes to sell to |
|
| March 16, 2020 |
Exhibit 99.1 Precipio Completes the Transaction with Poplar Healthcare’s Oncometrix Hematopathology Division Customer base and sales team transition to Precipio, Doubling Revenues NEW HAVEN, CT, (March 16, 2020) – Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has completed the non-cash transaction of the transition of Oncometrix’s customer base, as discussed |
|
| March 16, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 16, 2020 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer |
|
| February 18, 2020 |
Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership NEW HAVEN, CT, (February 18, 2020) – Specialty diagnostics company Precipio, Inc. |
|
| February 18, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 18, 2020 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employ |
|
| January 30, 2020 |
Up to 920,654 Shares of Common Stock Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933, as amended Registration 333-235911 PROSPECTUS Up to 920,654 Shares of Common Stock This prospectus relates to the offer and sale of up to 920,654 shares of common stock, par value $0. |
|
| January 29, 2020 |
PRPO / Precipio Inc CORRESP - - PRECIPIO, INC. 4 Science Park New Haven, Connecticut 06511 January 29, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Precipio, Inc. Registration Statement on Form S-1/A File No. 333-235911 Ladies and Gentleman, In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully reque |
|
| January 27, 2020 |
PRPO / Precipio Inc S-1/A - - FORM S-1/A As filed with the Securities and Exchange Commission on January 27, 2020 Registration No. |
|
| January 14, 2020 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name State of Incorporation or Organization Precipio Diagnostics, Inc. Connecticut |
|
| January 14, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 13, 2020 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employe |
|
| January 14, 2020 |
Precipio announces shareholder update call to kick off 2020 Exhibit 99.1 Precipio announces shareholder update call to kick off 2020 NEW HAVEN, CT, (January 13, 2020) – Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that on Monday, January 20th at 5pm it will conduct a shareholder update call with regard to several strategic initiatives for 2020 as well as the current status of IV-cell and Hemescreen deployment and the diversificati |
|
| January 14, 2020 |
PRPO / Precipio Inc S-1 - Registration Statement - FORM S-1 As filed with the Securities and Exchange Commission on January 14, 2020 Registration No. |
|
| December 4, 2019 |
Precipio Announces the Resignation of Samuel Riccitelli and the Introduction of Richard Sandberg to its Board of Directors Douglas Fisher, MD will assume the role of interim Chairman of the Board NEW HAVEN, CT, (December 4, 2019) – Specialty diagnostics company Precipio, Inc. |
|
| December 4, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 3, 2019 PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-36439 (Commission File Number) 91-1 |
|
| November 26, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 25, 2019 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employ |
|
| November 13, 2019 |
PRPO / Precipio Inc 10-Q - Quarterly Report - 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Numbe |
|
| November 5, 2019 |
Exhibit 99.1 Precipio Announces Q3-2019 Corporate Update Call for Shareholders Conference Call to be held on Wednesday, November 13th, 2019 at 5:30 PM EST NEW HAVEN, CT - (November 4th, 2019) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) will be hosting its Third Quarter 2019 corporate update call on Wednesday, November 13th at 5:30 PM ET. The conference call may be accessed |
|
| November 5, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 f8-k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8 - K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 4, 2019 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001‑36439 (Commission File Number) 91‑17 |
|
| October 2, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 2, 2019 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer |
|
| October 2, 2019 |
Exhibit 99.1 Precipio announces shareholder update call on commercial progress Conference call to be held Thursday October 10th at 5:00PM EST NEW HAVEN, CT, (October 2, 2019) – Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), will hold a shareholder update call where CEO Ilan Danieli will discuss the company’s commercial progress. The conference call may be accessed by calling 1-844-69 |
|
| September 26, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 26, 2019 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Emplo |
|
| September 26, 2019 |
Clinical Validations for IV-Cell™ and HemeScreen™ Completed Orders expected from several major labs both domestically and internationally NEW HAVEN, CT, (September 27, 2019) – Specialty diagnostics company Precipio, Inc. |
|
| August 21, 2019 |
Up to 1,800,000 shares Common Stock Filed pursuant to Rule 424(b)(3) Under the Securities Act of 1933, as amended Registration 333-233175 PROSPECTUS Up to 1,800,000 shares Common Stock This prospectus relates to the offer and sale of up to 1,800,000 shares of common stock, par value $0. |
|
| August 20, 2019 |
PRPO / Precipio Inc CORRESP - - Precipio, Inc. 4 Science Park New Haven, CT 06511 August 20, 2019 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Precipio, Inc. Registration Statement on Form S-1 File No. 333-233175 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Precipio, Inc. (the “ |
|
| August 13, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 13, 2019 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer |
|
| August 13, 2019 |
Precipio Announces Q2-2019 Corporate Update Call for Shareholders Conference Call to be held on Wednesday, August 21st, 2019 at 5:00 PM EST NEW HAVEN, CT - (August 13, 2019) – Specialty cancer diagnostics company Precipio, Inc. |
|
| August 9, 2019 |
TBIO / Transgenomic, Inc. S-1 - Registration Statement - FORM S-1 As filed with the Securities and Exchange Commission on August 9, 2019 Registration No. |
|
| August 9, 2019 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name State of Incorporation or Organization Precipio Diagnostics, Inc. Connecticut |
|
| August 9, 2019 |
PRPO / Precipio Inc 10-Q - Quarterly Report - 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 00 |
|
| June 20, 2019 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 17, 2019 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer I |
|
| June 20, 2019 |
Precipio CEO Provides Update Letter To Shareholders Precipio CEO Provides Update Letter To Shareholders NEW HAVEN, CT, (June 17, 2019) – Specialty diagnostics company Precipio, Inc. |
|
| June 19, 2019 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 19, 2019 PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer I |
